Atriopeptin III (rat) is a related natriuretic peptide used to analyze structural variation and receptor interaction dynamics. Its sequence supports mapping of functional motifs and ligand folding states. Researchers explore its conformation to understand peptide stability. The molecule contributes to comparative natriuretic peptide studies.
CAT No: A17050
CAS No:90817-13-3
Synonyms/Alias:Atriopeptin III;90817-13-3;Atriopeptin III (rat);Atriopeptin 24;Atriopeptin-24;UNII-2Q3V77H73V;Atrial natriuretic peptide (103-126);97793-28-7;Atriopeptin-21 (rat), 21a-L-phenylalanine-21b-L-arginine-21c-L-tyrosine-;atriopeptin-3;Atriopeptin 3;Atriopeptin III rat;Atriopeptin iii(rat);Atriopeptin III(TFA);atriopeptin (103-126);2Q3V77H73V;Atriopeptin III pound TFA pound(c);atrial natriuretic factor (103-126);DA-71126;FA108606;ANF (103-126);ANP (103-126);H-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH; H-SSCFGGRIDRIGAQSGLGCNSFRY-OH;
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.